TRANSETHOSOMES: A NEW PROSPECT FOR ENHANCED TRANSDERMAL DELIVERY

被引:18
|
作者
Shaji, Jessy [1 ]
Bajaj, Rinki [1 ]
机构
[1] Principal KM Kundnani Coll Pharm, Dept Pharmaceut, 23,Jote Joy Bldg,Rambhau Salgaonkar Marg, Mumbai 400005, Maharashtra, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2018年 / 9卷 / 07期
关键词
Transethosomes; Transdermal; Lipophilic; Drug absorption;
D O I
10.13040/IJPSR.0975-8232.9(7).2681-85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin covers a total surface area of approximately 1.8 m(2) and provides the contact between the human body and its external environment. Transdermal route of drug delivery has gained great interest in pharmaceutical research as it overcomes many problems associated with oral route of administration. Although the skin, particularly the stratum corneum presents a barrier to most drug absorption, it provides a large (1.2 m(2)) and accessible surface area for drug diffusion. Recently, various strategies have been used to augment the transdermal delivery of bioactives. Mainly, they include iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, magnetophoresis, microneedles, vesicular systems (liposomes, niosomes, elastic liposomes such as ethosomes, transfersomes and transethosomes). Among these transethosomes appear to be more promising as they possess both lipophilic and hydrophilic regions and can accommodate drug molecules with wide range of solubility. Transethosomes can deform and pass through narrow constriction that is 5 to 10 times less than its own diameter. This high deformability gives better penetration of intact vesicles. These vesicles can be used for transdermal delivery of various classes of drugs like analgesics, anesthetics, corticosteroids, sex hormones, anticancer agents insulin etc.
引用
收藏
页码:2681 / 2685
页数:5
相关论文
共 50 条
  • [21] Aceclofenac Ethosomes for Enhanced Transdermal Delivery
    Lewis, Shaila
    Dave, Vivek
    2009 INTERNATIONAL CONFERENCE ON BIOMEDICAL AND PHARMACEUTICAL ENGINEERING, 2009, : 88 - 91
  • [22] Enhanced penetration strategies for transdermal delivery
    Pan Qiaofei
    Yu Yinglin
    Chen Dong
    Jiao Genlong
    Liu Xiaowen
    FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING, 2020, 14 (03) : 378 - 388
  • [23] Transdermal Delivery Enhanced by Antimicrobial Peptides
    Kim, Yeu-Chun
    Ludovice, Peter J.
    Prausnitz, Mark R.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2010, 6 (05) : 612 - 620
  • [24] Enhanced transdermal delivery of tetracaine by electroporation
    Wu, QH
    Liang, WQ
    Bao, JL
    Ping, QN
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 202 (1-2) : 121 - 124
  • [25] Enhanced penetration strategies for transdermal delivery
    Qiaofei Pan
    Yinglin Yu
    Dong Chen
    Genlong Jiao
    Xiaowen Liu
    Frontiers of Chemical Science and Engineering, 2020, 14 : 378 - 388
  • [26] Enhanced transdermal insulin delivery by electroporation
    Ping, Wu
    Yuan-yuan, Yang
    Jia-li, Bao
    Xiao-an, Wang
    2008 INTERNATIONAL SPECIAL TOPIC CONFERENCE ON INFORMATION TECHNOLOGY AND APPLICATIONS IN BIOMEDICINE, VOLS 1 AND 2, 2008, : 314 - 317
  • [27] Ultrasound-enhanced transdermal drug delivery
    Makin, I
    Mensch, J
    Noppe, M
    Brewster, M
    JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) : 218 - 220
  • [28] Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin
    Abdellatif, Ahmed A. H.
    Tawfeek, Hesham M.
    AAPS PHARMSCITECH, 2016, 17 (05): : 1067 - 1074
  • [29] Transdermal delivery of piroxicam by surfactant enhanced electroporation
    Jiang, Guo-Qiang
    Zan, Jia
    Chen, Jun
    Zhu, De-Quan
    Ding, Fu-Xin
    Chinese Pharmaceutical Journal, 2004, 39 (02) : 117 - 119
  • [30] Development of the loratadine gel for enhanced transdermal delivery
    Song, Jae-Haeng
    Shin, Sang-Chul
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (08) : 897 - 903